Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. The company’s proprietary microfluidic 3D bioprinting technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
RX1 Bioprinter + portfolio of tissue products
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):